{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:10:02Z","timestamp":1770833402525,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007174","name":"Array BioPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.hrthm.2020.05.023","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T02:37:32Z","timestamp":1590201452000},"page":"1704-1710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ventricular tachycardia in cardiolaminopathy: Characteristics and considerations for device programming"],"prefix":"10.1016","volume":"17","author":[{"given":"Kiran","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-9661","authenticated-orcid":false,"given":"Larry","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kermshlise C.I.","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha B.","family":"Tedrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal K.","family":"Lakdawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.05.023_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/GIM.0b013e3181d6f7c0","article-title":"NIH public access","volume":"12","author":"Zimmerman","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2020.05.023_bib2","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.05.023_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"Van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/europace\/eut291","article-title":"Risk prediction of ventricular arrhythmias and myocardial function in lamin A\/C mutation positive subjects","volume":"16","author":"Hasselberg","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.05.023_bib6","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.05.023_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter experience with catheter ablation for ventricular tachycardia in lamin A\/C cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2018.10.016","article-title":"Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study","volume":"16","author":"Mahida","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.05.023_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euw332","article-title":"Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry","volume":"20","author":"Souissi","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.05.023_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2018.03.127","article-title":"Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials","volume":"267","author":"Maskoun","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib12","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.023_bib13","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/CIRCULATIONAHA.106.655720","article-title":"Catheter ablation for ventricular tachycardia","volume":"115","author":"Stevenson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.023_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.05.023_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jjcc.2019.03.019","article-title":"Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A\/C gene mutations","volume":"74","author":"Hasebe","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/eux166","article-title":"Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD)","volume":"20","author":"Guerra","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.05.023_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0735-1097(00)00733-6","article-title":"Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators","volume":"36","author":"B\u00e4nsch","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2006.03.037","article-title":"A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators. Results from the prospective randomized multicenter EMPIRIC trial","volume":"48","author":"Wilkoff","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.05.023_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/hc3101.093906","article-title":"Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease","volume":"104","author":"Wathen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.023_bib20","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","article-title":"Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.05.023_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120304574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120304574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:51:47Z","timestamp":1761547907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120304574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1547527120304574"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.023","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventricular tachycardia in cardiolaminopathy: Characteristics and considerations for device programming","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}